Mitochondrial dysfunction in cybrid lines expressing mitochondrial genes from patients with progressive supranuclear palsy
- PMID: 10987850
- DOI: 10.1046/j.1471-4159.2000.0751681.x
Mitochondrial dysfunction in cybrid lines expressing mitochondrial genes from patients with progressive supranuclear palsy
Abstract
Progressive supranuclear palsy (PSP) is a neurodegenerative movement disorder of unknown etiology. We hypothesized that mitochondrial DNA (mtDNA) aberration could occur in this disease and contribute to its pathogenesis. To address this we created transmitochondrial cytoplasmic hybrid (cybrid) cell lines expressing mitochondrial genes from persons with PSP. The presence of cybrid mtDNA aberration was screened for by biochemical assay of mitochondrial gene products. Relative to a control cybrid set, complex I activity was reduced in PSP cybrid lines (p<0.005). Antioxidant enzyme activities were elevated in PSP cybrid lines. These data suggest that mtDNA aberration occurs in PSP, causes electron transport chain pathology, and can produce oxidative stress. Further study of mitochondrial dysfunction in PSP may yield insights into why neurodegeneration occurs in this disease.
Similar articles
-
Biochemical analysis of cybrids expressing mitochondrial DNA from Contursi kindred Parkinson's subjects.Exp Neurol. 2001 Jun;169(2):479-85. doi: 10.1006/exnr.2001.7674. Exp Neurol. 2001. PMID: 11358461
-
Stress-induced mitochondrial depolarization and oxidative damage in PSP cybrids.Brain Res. 2002 Sep 27;951(1):31-5. doi: 10.1016/s0006-8993(02)03101-3. Brain Res. 2002. PMID: 12231453
-
Further evidence for mitochondrial dysfunction in progressive supranuclear palsy.Exp Neurol. 2001 Mar;168(1):196-8. doi: 10.1006/exnr.2000.7607. Exp Neurol. 2001. PMID: 11170735
-
New insights into progressive supranuclear palsy.Trends Neurosci. 2001 Jun;24(6):347-53. doi: 10.1016/s0166-2236(00)01794-x. Trends Neurosci. 2001. PMID: 11356507 Review.
-
Mitochondrial DNA--related mitochondrial dysfunction in neurodegenerative diseases.Arch Pathol Lab Med. 2002 Mar;126(3):271-80. doi: 10.5858/2002-126-0271-MDRMDI. Arch Pathol Lab Med. 2002. PMID: 11860299 Review.
Cited by
-
Progressive supranuclear palsy: Advances in diagnosis and management.Parkinsonism Relat Disord. 2020 Apr;73:105-116. doi: 10.1016/j.parkreldis.2020.04.014. Epub 2020 May 25. Parkinsonism Relat Disord. 2020. PMID: 32487421 Free PMC article. Review.
-
Novel Therapies for Parkinsonian Syndromes-Recent Progress and Future Perspectives.Front Mol Neurosci. 2021 Aug 26;14:720220. doi: 10.3389/fnmol.2021.720220. eCollection 2021. Front Mol Neurosci. 2021. PMID: 34512258 Free PMC article. Review.
-
POLG and PEO1 (Twinkle) mutations are infrequent in PSP-like atypical parkinsonism: a preliminary screening study.J Neurol. 2012 Oct;259(10):2232-3. doi: 10.1007/s00415-012-6535-1. Epub 2012 May 12. J Neurol. 2012. PMID: 22580846 No abstract available.
-
Associations of mitochondrial genomic variation with corticobasal degeneration, progressive supranuclear palsy, and neuropathological tau measures.Acta Neuropathol Commun. 2020 Sep 17;8(1):162. doi: 10.1186/s40478-020-01035-z. Acta Neuropathol Commun. 2020. PMID: 32943110 Free PMC article.
-
Progressive supranuclear palsy.Mol Pathol. 2001 Dec;54(6):427-34. Mol Pathol. 2001. PMID: 11724919 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
